FDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly …
Jun 28, 2023 · New, longer-acting treatment offers option to reduce the frequency of injections for children with growth hormone deficiency from daily to once-weekly Pfizer Inc. (NYSE: PFE) …
Once-weekly SKYTROFA® (lonapegsomatropin-tcgd)
More injection-free days with once-weekly dosing compared with daily therapies Convenient storage with no required refrigeration for up to 6 months* and no preservatives Higher growth …
Growth Hormone Treatment | Sogroya® (somapacitan-beco) …
Sogroya® (somapacitan-beco) injection is a once-weekly growth hormone injection used to treat children aged 2.5 years or older and adults with growth hormone deficiency (GHD). Read …
Novo Nordisk A/S: Once-weekly Sogroya® (somapacitan) is an
May 12, 2025 · About once-weekly Sogroya® Once-weekly Sogroya ® (somapacitan) is a prescription human growth hormone analogue, similar to current daily growth hormone.
NGENLA™ (somatrogon-ghla) Injection for Pediatric GHD | Safety …
Children taking once-weekly NGENLA for 1 year had on average a similar growth rate to children taking once-daily growth hormone treatment. Not an actual patient.
Once-weekly SKYTROFA® (lonapegsomatropin-tcgd) | HCP Website
Explore the benefits of once-weekly SKYTROFA® (lonapegsomatropin-tcgd) and learn how SKYTROFA may fit into your clinical approach. Please see full Prescribing and Safety …
Skytrofa Approved as Once-Weekly Option for Adults With Growth Hormone …
Jul 29, 2025 · Skytrofa (lonapegsomatropin-tcgd), a long-acting version of human growth hormone (hGH), is now approved for adults with GHD.
FDA approves weekly therapy for adult growth hormone deficiency
FDA approved Sogroya (somapacitan) on August 28 for adults with growth hormone deficiency. Sogroya is the first human growth hormone (hGH) therapy that adult patients only take once a …
Sogroya® (somapacitan-beco) injection 10 mg Growth Hormone …
The first once-weekly treatment approved for both pediatric and adult patients with GHD 2 a Based on data from Komodo Sentinel as of February 2025. b Based on a randomized, …
Ngenla: Uses, Dosage, Side Effects, Warnings - Drugs.com
Mar 13, 2025 · Ngenla is a long-acting human growth hormone used to treat children aged 3 and older who are not growing because of growth hormone deficiency (GHD). It is given by …